Real-world retrospective analysis of patient characteristics, healthcare resource utilization, costs, and treatment patterns among unvaccinated adults with COVID-19 diagnosed in outpatient settings in the United States

References

• World Health Organization. Timeline: WHO's COVID-19 Response. [cited 2022 February 9]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/interactive-timeline#.
   Google Scholar
• Centers for Disease Control and Prevention. First Travel-Related Case of 2019 Novel Coronavirus Detected in United States. 2020. [cited 2022 February 9]. Available from: https://www.cdc.gov/media/releases/2020/p0121-novel-coronavirus-travel-case.html.
   Google Scholar
• Centers for Disease Control and Prevention. United States COVID-19 Cases, Deaths, and Laboratory Testing (NAATs) by State, Territory, and Jurisdiction. 2021. [cited 2021 December 15]. Available from: https://covid.cdc.gov/covid-data-tracker/#cases_totalcases.
   Google Scholar
• National Institutes of Health. Clinical Management Summary. 2021. [cited 2022 January 19]. Available from: https://www.covid19treatmentguidelines.nih.gov/management/clinical-management/clinical-management-summary/.
   Google Scholar
• Centers for Disease Control and Prevention. COVID Data Tracker. 2021. [cited 2021 December 15]. Available from: https://covid.cdc.gov/covid-data-tracker/#new-hospital-admissions.
   Google Scholar
• National Institutes of Health. General Management of Nonhospitalized patients with acute COVID-19. 2021. [cited 2021 September 27]. Available from: https://www.covid19treatmentguidelines.nih.gov/management/clinical-management/nonhospitalized-patients–general-management/.
   Google Scholar
• US Food and Drug Administration. Coronavirus (COVID-19) update: FDA authorizes first oral antiviral for treatment of COVID-19. 2021. [cited 2022 February 9]. Available from: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-oral-antiviral-treatment-covid-19.
   Google Scholar
• US Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Authorizes Additional Oral Antiviral for Treatment of COVID-19 in Certain Adults. 2021. [cited 2022 February 9]. Available from: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-additional-oral-antiviral-treatment-covid-19-certain.
   Google Scholar
• Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020;369:m1966.
   PubMed Web of Science ®Google Scholar
• Stokes EK, Zambrano LD, Anderson KN, et al. Coronavirus disease 2019 case surveillance – United States, January 22-May 30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(24):759–765.
   PubMed Web of Science ®Google Scholar
• Lavery AM, Preston LE, Ko JY, et al. Characteristics of hospitalized COVID-19 patients discharged and experiencing same-hospital readmission — United States, March–August 2020. MMWR Morb Mortal Wkly Rep. 2020;69(45):1695–1699.
   PubMed Web of Science ®Google Scholar
• Cunningham JW, Vaduganathan M, Claggett BL, et al. Clinical outcomes in young US adults hospitalized with COVID-19. JAMA Intern Med. 2021;181(3):379–381.
   Web of Science ®Google Scholar
• Rosenthal N, Cao Z, Gundrum J, et al. Risk factors associated with in-hospital mortality in a US national sample of patients with COVID-19. JAMA Netw Open. 2020;3(12):e2029058.
   PubMed Web of Science ®Google Scholar
• Ioannou GN, Locke E, Green P, et al. Risk factors for hospitalization, mechanical ventilation, or death among 10131 US veterans with SARS-CoV-2 infection. JAMA Netw Open. 2020;3(9):e2022310.
   PubMed Web of Science ®Google Scholar
• Lin KJ, Schneeweiss S, Tesfaye H, et al. Pharmacotherapy for hospitalized patients with COVID-19: treatment patterns by disease severity. Drugs. 2020;80(18):1961–1972.
   PubMed Web of Science ®Google Scholar
• Nguyen NT, Chinn J, Nahmias J, et al. Outcomes and mortality among adults hospitalized with COVID-19 at US medical centers. JAMA Netw Open. 2021;4(3):e210417.
   PubMed Web of Science ®Google Scholar
• Best JH, Kong AM, Kaplan-Lewis E, et al. Treatment patterns in US patients hospitalized with COVID-19 and pulmonary involvement. J Med Virol. 2021;93(9):5367–5375.
   PubMed Web of Science ®Google Scholar
• Di Fusco M, Shea KM, Lin J, et al. Health outcomes and economic burden of hospitalized COVID-19 patients in the United States. J Med Econ. 2021;24(1):308–317.
   PubMed Web of Science ®Google Scholar
• Blair PW, Brown DM, Jang M, et al. The clinical course of COVID-19 in the outpatient setting: a prospective cohort study. Open Forum Infect Dis. 2021;8(2):ofab007.
   Web of Science ®Google Scholar
• Wei W, Sivapalasingam S, Mellis S, et al. A retrospective study of COVID-19-related urgent medical visits and hospitalizations after outpatient COVID-19 diagnosis in the US. Adv Ther. 2021;38(6):3185–3202.
   PubMed Web of Science ®Google Scholar
• Fernandez-de-Las-Penas C, Palacios-Cena D, Gomez-Mayordomo V, et al. Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: a systematic review and meta-analysis. Eur J Intern Med. 2021;92:55–70.
   PubMed Web of Science ®Google Scholar
• Jacobson KB, Rao M, Bonilla H, et al. Patients with uncomplicated coronavirus disease 2019 (COVID-19) have long-term persistent symptoms and functional impairment similar to patients with severe COVID-19: a cautionary tale during a global pandemic. Clin Infect Dis. 2021;73(3):e826–e829.
   PubMed Web of Science ®Google Scholar
• Carvalho-Schneider C, Laurent E, Lemaignen A, et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2021;27(2):258–263.
   PubMed Web of Science ®Google Scholar
• Tenforde MW, Kim SS, Lindsell CJ, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network—United States, March–June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(30):993–998.
   PubMed Web of Science ®Google Scholar
• Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594(7862):259–264.
   PubMed Web of Science ®Google Scholar
• Kubota T, Kuroda N. Exacerbation of neurological symptoms and COVID-19 severity in patients with preexisting neurological disorders and COVID-19: a systematic review. Clin Neurol Neurosurg. 2021;200:106349.
   PubMed Web of Science ®Google Scholar
• Unudurthi SD, Luthra P, Bose RJC, et al. Cardiac inflammation in COVID-19: lessons from heart failure. Life Sci. 2020;260:118482.
   PubMed Web of Science ®Google Scholar
• CDC COVID-19 Response Team. SARS-CoV-2 B.1.1.529 (omicron) Variant — United States, December 1–8, 2021. MMWR Morb Mortal Wkly Rep. 2021;70:1731–1734.
   PubMed Web of Science ®Google Scholar
• Hernandez-Romieu AC, Leung S, Mbanya A, et al. Health care utilization and clinical characteristics of nonhospitalized adults in an integrated health care system 28–180 days after COVID-19 diagnosis — Georgia, May 2020–March 2021. MMWR Morb Mortal Wkly Rep. 2021;70(17):644–650.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. People With Certain Medical Conditions. 2021. [cited 2021 October 4]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html.
   Google Scholar
• Yih WK, Hua W, Draper C, et al. Sentinel COVID-19 Natural History Master Protocol. 2020. [cited 2022 February 9]. Available from: https://www.sentinelinitiative.org/sites/default/files/Methods/COVID-19-Natural_History_Protocol_v3.0.pdf.
   Google Scholar
• Federici C, Cavazza M, Costa F, et al. Health care costs of influenza-related episodes in high income countries: a systematic review. PLOS One. 2018;13(9):e0202787.
   PubMed Web of Science ®Google Scholar
• Marbus SD, Schweitzer VA, Groeneveld GH, et al. Incidence and costs of hospitalized adult influenza patients in The Netherlands: a retrospective observational study. Eur J Health Econ. 2020;21(5):775–785.
   PubMed Web of Science ®Google Scholar
• Putri W, Muscatello DJ, Stockwell MS, et al. Economic burden of seasonal influenza in the United States. Vaccine. 2018;36(27):3960–3966.
   PubMed Web of Science ®Google Scholar
• World Health Organization. A Clinical Case Definition of Post COVID-19 Condition by a Delphi Consensus, 6 October 2021. 2021. [cited 2022 February 9]. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1.
   Google Scholar